Subtopic Deep Dive
Virus-Like Particle Vaccine Production
Research Guide
What is Virus-Like Particle Vaccine Production?
Virus-Like Particle (VLP) vaccine production involves expressing viral structural proteins in insect and mammalian cells to self-assemble into non-infectious particles for vaccines against HPV, HBV, and norovirus.
Baculovirus vectors enable high-yield VLP expression in insect cells (Kost et al., 2005, 989 citations). Mammalian cells support VLP assembly with proper glycosylation for immunogenicity (O’Flaherty et al., 2020, 234 citations). Over 20 papers detail optimization of assembly and multivalent display using these systems.
Why It Matters
VLPs power commercial HPV vaccines like Gardasil by eliciting strong antibody responses without viral replication risks (Touzé, 1998). Insect cell systems scale production for pandemics, as in norovirus vaccine trials (Kost et al., 2005; Cid and Bolívar, 2021). Tripathi and Shrivastava (2019) highlight VLP bioprocessing for global infectious disease control, reducing subunit vaccine limitations.
Key Research Challenges
VLP Assembly Optimization
Incomplete self-assembly in insect cells reduces VLP yield and uniformity (Kost et al., 2005). Glycosylation differences between insect and mammalian hosts alter immunogenicity (O’Flaherty et al., 2020). Process parameters like pH and shear force impact particle integrity (Tapia et al., 2016).
Scalable Bioreactor Production
High cell density cultivations face oxygen transfer limits in VLP processes (Gallo–Ramírez et al., 2015, 113 citations). Continuous multi-stage bioreactors require contamination control for insect cell VLPs (Tapia et al., 2016). Yield drops occur beyond 10^7 cells/mL (Tripathi and Shrivastava, 2019).
Immunogenicity Enhancement
Insect-expressed VLPs show weaker responses than mammalian due to glycosylation (Hu, 2005). Multivalent display for HBV/norovirus needs adjuvant optimization (Shirbaghaee and Bolhassani, 2015). Stability during purification affects epitope presentation (Cid and Bolívar, 2021).
Essential Papers
Baculovirus as versatile vectors for protein expression in insect and mammalian cells
Thomas A. Kost, J. Patrick Condreay, Donald L. Jarvis · 2005 · Nature Biotechnology · 989 citations
Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development
Nagesh K. Tripathi, Ambuj Shrivastava · 2019 · Frontiers in Bioengineering and Biotechnology · 531 citations
Infectious diseases, along with cancers, are among the main causes of death among humans worldwide. The production of therapeutic proteins for treating diseases at large scale for millions of indiv...
Mammalian cell culture for production of recombinant proteins: A review of the critical steps in their biomanufacturing
Róisín O’Flaherty, Adam Bergin, Evangelia Flampouri et al. · 2020 · Biotechnology Advances · 234 citations
The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice
Christie Bell, Luk H. Vandenberghe, Peter Bell et al. · 2011 · Journal of Clinical Investigation · 186 citations
Vectors based on adeno-associated virus (AAV) serotype 9 are candidates for in vivo gene delivery to many organs, but the receptor(s) mediating these tropisms have yet to be defined. We evaluated A...
Baculovirus as a highly efficient expression vector in insect and mammalian cells
Yu‐Chen Hu · 2005 · Acta Pharmacologica Sinica · 172 citations
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
Raquel Cid, Jorge Bolı́var · 2021 · Biomolecules · 155 citations
To date, vaccination has become one of the most effective strategies to control and reduce infectious diseases, preventing millions of deaths worldwide. The earliest vaccines were developed as live...
Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production
Felipe Tapia, Daniel Vázquez-Ramírez, Yvonne Genzel et al. · 2016 · Applied Microbiology and Biotechnology · 148 citations
Reading Guide
Foundational Papers
Start with Kost et al. (2005, 989 citations) for baculovirus-insect VLP basics; Touzé (1998) for HPV VLP gene transfer; Hu (2005) for expression efficiency comparisons.
Recent Advances
Tripathi and Shrivastava (2019) for bioprocessing advances; O’Flaherty et al. (2020) for mammalian scaling; Cid and Bolívar (2021) for next-gen VLP platforms.
Core Methods
Baculovirus/insect cell expression (Kost 2005); bioreactor high-density culture (Tapia 2016); mammalian glycosylation optimization (O’Flaherty 2020).
How PapersFlow Helps You Research Virus-Like Particle Vaccine Production
Discover & Search
Research Agent uses searchPapers with 'baculovirus VLP insect cells' to retrieve Kost et al. (2005, 989 citations), then citationGraph reveals 500+ downstream papers on HPV VLPs. exaSearch on 'norovirus VLP bioreactor scaling' surfaces Tapia et al. (2016); findSimilarPapers links to Cid and Bolívar (2021) for multivalent strategies.
Analyze & Verify
Analysis Agent runs readPaperContent on Kost et al. (2005) to extract baculovirus titers, then verifyResponse with CoVe cross-checks claims against Tripathi (2019). runPythonAnalysis processes VLP yield data from O’Flaherty et al. (2020) via pandas for statistical comparison of insect vs. mammalian expression (GRADE: A for yield metrics).
Synthesize & Write
Synthesis Agent detects gaps in multivalent HBV VLP immunogenicity from Shirbaghaee (2015) and Hu (2005). Writing Agent applies latexEditText to draft methods section, latexSyncCitations for 15 VLP papers, and latexCompile for publication-ready manuscript. exportMermaid visualizes baculovirus expression pipeline from Kost (2005).
Use Cases
"Compare VLP yields in insect vs mammalian cells for HPV vaccine production"
Research Agent → searchPapers + citationGraph (Kost 2005) → Analysis Agent → runPythonAnalysis (pandas plot yields from 5 papers) → CSV export of stats table.
"Draft LaTeX review on baculovirus VLP scaling challenges"
Synthesis Agent → gap detection (Tapia 2016 gaps) → Writing Agent → latexEditText + latexSyncCitations (10 papers) + latexCompile → PDF with bioreactor diagram.
"Find open-source code for VLP assembly simulation in insect cells"
Research Agent → paperExtractUrls (Tripathi 2019) → Code Discovery → paperFindGithubRepo + githubRepoInspect → Python scripts for Monte Carlo VLP assembly modeling.
Automated Workflows
Deep Research workflow scans 50+ VLP papers via searchPapers, structures report on insect expression (Kost 2005 baseline), and flags bioreactor gaps (Tapia 2016). DeepScan applies 7-step CoVe to verify Touzé (1998) HPV VLP claims against recent Cid (2021). Theorizer generates hypotheses on glycosylation engineering from Hu (2005) + O’Flaherty (2020) contradictions.
Frequently Asked Questions
What defines Virus-Like Particle vaccine production?
Expression of viral capsid proteins in insect/mammalian cells to form non-infectious VLPs mimicking viruses for HPV/HBV vaccines (Kost et al., 2005).
What are key methods for VLP production?
Baculovirus vectors in Sf9 insect cells for high-yield expression; mammalian HEK293 for glycosylation (Hu, 2005; O’Flaherty et al., 2020).
What are the most cited papers?
Kost et al. (2005, 989 citations) on baculovirus vectors; Tripathi (2019, 531 citations) on bioprocessing; Touzé (1998, 144 citations) on HPV VLPs.
What open problems exist?
Scaling VLPs to 100g/L in bioreactors; enhancing insect VLP immunogenicity via glycoengineering (Tapia et al., 2016; Shirbaghaee, 2015).
Research Viral Infectious Diseases and Gene Expression in Insects with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Virus-Like Particle Vaccine Production with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers